SUNSHINE BIOPHARMA INC's ticker is and the CUSIP is 867781403. A total of 10 filers reported holding SUNSHINE BIOPHARMA INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,870 | -35.5% | 6,042 | 0.0% | 0.00% | – |
Q2 2023 | $2,900 | -31.4% | 6,042 | 0.0% | 0.00% | – |
Q1 2023 | $4,230 | +9.4% | 6,042 | 0.0% | 0.00% | – |
Q4 2022 | $3,867 | +286.7% | 6,042 | +479.8% | 0.00% | – |
Q3 2022 | $1,000 | 0.0% | 1,042 | 0.0% | 0.00% | – |
Q2 2022 | $1,000 | -66.7% | 1,042 | 0.0% | 0.00% | – |
Q1 2022 | $3,000 | – | 1,042 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 568,400 | $614,000 | 0.01% |
Virtu Financial LLC | 47,861 | $52,000 | 0.00% |
Dakota Wealth Management | 20,000 | $22,000 | 0.00% |
TWO SIGMA SECURITIES, LLC | 20,722 | $22,000 | 0.00% |
BANK OF AMERICA CORP /DE/ | 3,330 | $4,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 20,179 | $21,000 | 0.00% |
CITIGROUP INC | 130 | $0 | 0.00% |
MORGAN STANLEY | 6,867 | $7,000 | 0.00% |
NATIONAL BANK OF CANADA /FI/ | 1,042 | $1,000 | 0.00% |